These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10698441)

  • 1. Structure-activity relationships of carboxymethylpullulan-peptide-doxorubicin conjugates--systematic modification of peptide spacers.
    Nogusa H; Yano T; Kashima N; Yamamoto K; Okuno S; Hamana H
    Bioorg Med Chem Lett; 2000 Feb; 10(3):227-30. PubMed ID: 10698441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution characteristics of carboxymethylpullulan-peptide-doxorubicin conjugates in tumor-bearing rats: different sequence of peptide spacers and doxorubicin contents.
    Nogusa H; Yamamoto K; Yano T; Kajiki M; Hamana H; Okuno S
    Biol Pharm Bull; 2000 May; 23(5):621-6. PubMed ID: 10823676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects and toxicities of carboxymethylpullulan-peptide-doxorubicin conjugates.
    Nogusa H; Yano T; Kajiki M; Gonsho A; Hamana H; Okuno S
    Biol Pharm Bull; 1997 Oct; 20(10):1061-5. PubMed ID: 9353565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of carboxymethylpullulan-peptide-doxorubicin conjugates and their properties.
    Nogusa H; Yano T; Okuno S; Hamana H; Inoue K
    Chem Pharm Bull (Tokyo); 1995 Nov; 43(11):1931-6. PubMed ID: 8575033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates.
    Nogusa H; Hamana H; Uchida N; Maekawa R; Yoshioka T
    Jpn J Cancer Res; 2000 Dec; 91(12):1333-8. PubMed ID: 11123434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells.
    Asakura T; Takahashi N; Takada K; Inoue T; Ohkawa K
    Anticancer Drugs; 1997 Feb; 8(2):199-203. PubMed ID: 9073316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates.
    Shiose Y; Kuga H; Ohki H; Ikeda M; Yamashita F; Hashida M
    Bioconjug Chem; 2009 Jan; 20(1):60-70. PubMed ID: 19090781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental treatment of malignant gliomas with human monoclonal antibody-drug conjugates.
    Takahashi H; Adachi K; Yamaguchi F; Teramoto A
    Anticancer Res; 1999; 19(5B):4151-5. PubMed ID: 10628367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carboxymethylpullulan as a novel carrier for targeting immune tissues.
    Masuda K; Sakagami M; Horie K; Nogusa H; Hamana H; Hirano K
    Pharm Res; 2001 Feb; 18(2):217-23. PubMed ID: 11405294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell).
    Meyer-Losic F; Quinonero J; Dubois V; Alluis B; Dechambre M; Michel M; Cailler F; Fernandez AM; Trouet A; Kearsey J
    J Med Chem; 2006 Nov; 49(23):6908-16. PubMed ID: 17154520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel peptide conjugates for tumor-specific chemotherapy.
    Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG
    J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.
    Garsky VM; Lumma PK; Feng DM; Wai J; Ramjit HG; Sardana MK; Oliff A; Jones RE; DeFeo-Jones D; Freidinger RM
    J Med Chem; 2001 Nov; 44(24):4216-24. PubMed ID: 11708923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.
    Lelle M; Frick SU; Steinbrink K; Peneva K
    J Pept Sci; 2014 May; 20(5):323-33. PubMed ID: 24677287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the sialyl Lewis X (SLe(x)) moiety on splenic accumulation of SLe(x)-carboxymethylpullulan conjugate.
    Horie K; Sakagami M; Kuramochi K; Ito T; Hamana H
    Microbiol Immunol; 2000; 44(5):401-4. PubMed ID: 10888360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity.
    Liang JF; Yang VC
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5071-5. PubMed ID: 16168650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialyl Lewis X-carboxymethylpullulan conjugate: a novel homing device to spleen and lymph nodes.
    Horie K; Sakagami M; Masuda K; Notoya M; Hamana H; Yoshikawa T; Hirano K
    Biol Pharm Bull; 2004 Aug; 27(8):1275-80. PubMed ID: 15305036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced accumulation of sialyl Lewis X-carboxymethylpullulan conjugate in acute inflammatory lesion.
    Horie K; Sakagami M; Kuramochi K; Hanasaki K; Hamana H; Ito T
    Pharm Res; 1999 Feb; 16(2):314-20. PubMed ID: 10100320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes.
    Yang Y; Yan Z; Wei D; Zhong J; Liu L; Zhang L; Wang F; Wei X; Xie C; Lu W; He D
    Nanotechnology; 2013 Oct; 24(40):405101. PubMed ID: 24029287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells.
    Balasso A; Salmaso S; Pontisso P; Rosato A; Quarta S; Malfanti A; Mastrotto F; Caliceti P
    Eur J Pharm Sci; 2017 May; 103():104-115. PubMed ID: 28192167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.